JUN and head and neck squamous cell carcinoma: Taken together, these data strongly support the notion that GNA13-induced TIC phenotype is mediated via activation of NFκB and JNK/MAPK-AP-1 signaling pathways, and that blocking these pathways can re-sensitize the HNSCC cells to cisplatin treatment.